Second International Conference on Polymyxins

Significant progress has been made in the clinical use and pharmacology of polymyxins, in particular understanding how they should be dosed in particular types of patients,identification of the risk factors for nephrotoxicity and its mechanisms, and discovery of novel polymyxin-like antibiotics. The conference will feature cutting-edge presentations by internationally leading clinicians, scientists, and regulatory agency representatives on topics pertaining to the use of these drugs. Get more information at  http://monash.edu/pharm/about/events/polymyxins/registration.html